Aurobindo Pharma Ltd
NSE :AUROPHARMA BSE :524804 Sector : PharmaceuticalsBuy, Sell or Hold AUROPHARMA? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
07 May 1124.35 (-3.34%) | 06 May 1163.20 (1.00%) | 03 May 1151.65 (-0.41%) | 02 May 1156.35 (0.25%) | 30 Apr 1153.50 (0.15%) | 29 Apr 1151.80 (1.81%) | 26 Apr 1131.30 (2.53%) | 25 Apr 1103.40 (1.78%) | 24 Apr 1084.05 (-0.84%) | 23 Apr 1093.25 (1.58%) | 22 Apr 1076.25 (-0.99%) | 19 Apr 1087.05 (-2.46%) | 18 Apr 1114.50 (0.31%) | 16 Apr 1111.10 (2.38%) | 15 Apr 1085.30 (-0.29%) | 12 Apr 1088.45 (-1.82%) | 10 Apr 1108.65 (-2.06%) | 09 Apr 1131.95 (1.04%) | 08 Apr 1120.25 (-0.31%) | 05 Apr 1123.70 (0.01%) | 04 Apr 1123.60 (-1.24%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bullish
Medium Term Investors
Very Bullish
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bearish
1149.35
10 DMA
Bearish
1130.99
20 DMA
Bullish
1117.78
50 DMA
Bullish
1078.21
100 DMA
Bullish
1076.92
200 DMA
Bullish
983.38
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On May 07, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1236.76 | 1203.38 | 1144.4 | - | - |
R2 | 1203.38 | 1175.53 | 1137.72 | 1201.85 | - |
R1 | 1163.86 | 1158.33 | 1131.03 | 1160.8 | 1183.63 |
P | 1130.48 | 1130.48 | 1130.48 | 1128.95 | 1140.36 |
S1 | 1090.96 | 1102.63 | 1117.67 | 1087.9 | 1110.73 |
S2 | 1057.58 | 1085.43 | 1110.99 | 1056.05 | - |
S3 | 1018.06 | 1057.58 | 1104.3 | - | - |
Key Metrics
EPS
33.56
P/E
33.51
P/B
3.53
Dividend Yield
0.67%
Market Cap
65,880 Cr.
Face Value
1
Book Value
318.55
ROE
7.5%
EBITDA Growth
1,760.24 Cr.
Debt/Equity
0.16
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Aurobindo Pharma Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 6499.78 | 6607.87 | 6966.85 | 7407.3 | 7514.3 |
PROFIT | 491.26 | 506.27 | 611.26 | 757.18 | 936.29 |
EPS | 8.38 | 8.64 | 9.74 | 12.83 | 16.04 |
Aurobindo Pharma Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 2438.92 | 2686.19 | 2503.65 | 2771.93 | 3023.16 |
PROFIT | 322.94 | 644.8 | 318 | 379.65 | 623.78 |
EPS | 5.1 | 10.22 | 5.74 | 7.1 | 10.65 |
Profit & Loss (Figures in Rs. Crores)
Aurobindo Pharma Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 8223.35 | 12546.71 | 14092.78 | 15339.65 | 17050.67 | 20397.12 | 23392.24 | 29135.18 | 23075.19 | 25555.65 | |
PROFIT | 1175.09 | 1587.14 | 2028.78 | 2306.24 | 2423.17 | 2430.63 | 2864.68 | 3410.14 | 2757.17 | 1919.7 | |
EPS | 19.8 | 26.48 | 34.58 | 38.88 | 41.35 | 40.36 | 48.54 | 91.04 | 45.18 | 32.9 |
Aurobindo Pharma Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 7221.26 | 8321.41 | 9496.13 | 9711.68 | 10684.73 | 12746.91 | 13998.23 | 16410.55 | 11912.62 | 13692.04 | |
PROFIT | 1173.5 | 1518.29 | 1627.51 | 1720.3 | 1812.82 | 1537.74 | 1878.78 | 3113.04 | 1535.98 | 1220.43 | |
EPS | 19.85 | 25.54 | 27.8 | 28.73 | 30.94 | 26.11 | 32.03 | 53.13 | 24.83 | 21 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 | 29.2 | 29.15 |
Reserves Total | 26,781.26 | 24,517.39 | 21,871.28 | 16,766.08 | 13,832.19 | 11,621.83 | 9,313.32 | 7,228.78 | 5,126.71 | 3,721 |
Total Shareholders Funds | 26,839.85 | 24,575.98 | 21,929.87 | 16,824.67 | 13,890.78 | 11,680.42 | 9,371.91 | 7,287.3 | 5,155.91 | 3,750.15 |
Minority Interest | 12 | -1.93 | -0.88 | 0.14 | 1.59 | 1.82 | 2.08 | 2.55 | 25.82 | 25.67 |
Secured Loans | 2,557.37 | 543.69 | 1,053.55 | 1,314.97 | 1,661.87 | 419.18 | 640.8 | 2,285.15 | 2,081.94 | 2,606.44 |
Unsecured Loans | 2,728.84 | 2,307.58 | 4,285.53 | 4,511.41 | 5,304.89 | 4,350.75 | 2,723.34 | 2,755.92 | 2,369.13 | 1,162.7 |
Total Debt | 5,286.21 | 2,851.27 | 5,339.08 | 5,826.38 | 6,966.76 | 4,769.93 | 3,364.14 | 5,041.07 | 4,451.07 | 3,769.14 |
Other Liabilities | 214.26 | 212.91 | 250.71 | 162.19 | 80.16 | 66.43 | 39.13 | 23.36 | 24.35 | 9.18 |
Total Liabilities | 32,352.32 | 27,638.23 | 27,518.78 | 22,813.38 | 20,939.29 | 16,518.6 | 12,777.26 | 12,354.28 | 9,657.15 | 7,554.14 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 18,143.23 | 15,524.55 | 13,613.33 | 12,441.26 | 10,497.62 | 7,894.78 | 5,635.49 | 4,569.83 | 5,446.13 | 4,182.96 |
Less: Accumulated Depreciation | 7,119.54 | 4,992.46 | 4,239.75 | 3,044.79 | 2,022.77 | 1,374.1 | 801.71 | 390.14 | 1,740.49 | 1,461.29 |
Net Block | 11,023.69 | 10,532.09 | 9,373.58 | 9,396.47 | 8,474.85 | 6,520.68 | 4,833.78 | 4,179.69 | 3,705.64 | 2,721.67 |
Capital Work in Progress | 5,390.01 | 3,747.2 | 3,061.53 | 1,985.92 | 1,668.46 | 1,583.04 | 1,458.08 | 848.14 | 419.63 | 309.72 |
Investments | 542.74 | 997.15 | 591.01 | 554.71 | 360.22 | 311.54 | 245.87 | 122.96 | 19.79 | 19.79 |
Inventories | 8,516.11 | 7,559.08 | 9,041.18 | 7,699.87 | 7,245.6 | 5,858.41 | 4,330.54 | 4,056.14 | 3,611.3 | 2,367.54 |
Sundry Debtors | 4,466.38 | 4,012.26 | 3,503.28 | 4,315.16 | 3,413.78 | 3,080.2 | 2,765.33 | 4,606.68 | 3,539.17 | 2,636.57 |
Cash and Bank Balance | 6,084.2 | 4,190.01 | 5,474.28 | 2,842.15 | 1,957.18 | 1,262.25 | 513.48 | 800.26 | 469.11 | 178.58 |
Loans and Advances | 2,332.86 | 1,987.72 | 1,659.59 | 1,555.31 | 2,715.72 | 1,977.28 | 1,596.81 | 831.25 | 659.57 | 448.46 |
Total Current Assets | 21,399.55 | 17,749.07 | 19,678.33 | 16,412.49 | 15,332.28 | 12,178.14 | 9,206.16 | 10,294.33 | 8,279.15 | 5,631.15 |
Current Liabilities | 6,735.93 | 5,643.94 | 5,378.37 | 5,310.95 | 4,849.09 | 4,052.93 | 3,161.5 | 3,409.03 | 2,828.56 | 1,603.66 |
Provisions | 417.01 | 233.82 | 396.89 | 511.72 | 384.67 | 294.23 | 261.36 | 132.93 | 218.24 | 126.6 |
Total Current Liabilities & Provisions | 7,152.94 | 5,877.76 | 5,775.26 | 5,822.67 | 5,233.76 | 4,347.16 | 3,422.86 | 3,541.96 | 3,046.8 | 1,730.26 |
Net Current Assets | 14,246.61 | 11,871.31 | 13,903.07 | 10,589.82 | 10,098.52 | 7,830.98 | 5,783.3 | 6,752.37 | 5,232.35 | 3,900.89 |
Deferred Tax Assets | 768.88 | 429.74 | 600.91 | 163.2 | 183.29 | 539.17 | 501.82 | 227.37 | 33.3 | 18.61 |
Deferred Tax Liability | 481 | 552.11 | 722.79 | 291.69 | 281.31 | 615.65 | 383.36 | 45.05 | 239.08 | 223.98 |
Net Deferred Tax | 287.88 | -122.37 | -121.88 | -128.49 | -98.02 | -76.48 | 118.46 | 182.32 | -205.78 | -205.37 |
Other Assets | 861.39 | 612.85 | 711.47 | 414.95 | 435.26 | 348.84 | 337.77 | 268.8 | 485.52 | 807.44 |
Total Assets | 32,352.32 | 27,638.23 | 27,518.78 | 22,813.38 | 20,939.29 | 16,518.6 | 12,777.26 | 12,354.28 | 9,657.15 | 7,554.14 |
Contingent Liabilities | 158.53 | 157.74 | 140.83 | 145.98 | 133.71 | 211.79 | 196.97 | 177.11 | 195.38 | 151.36 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 | 29.2 | 29.15 |
Reserves Total | 17,855.58 | 17,058.75 | 15,866.02 | 12,993.91 | 11,292.03 | 9,923.99 | 8,377.59 | 6,807.33 | 5,330.34 | 3,983.24 |
Total Shareholders Funds | 17,914.17 | 17,117.34 | 15,924.61 | 13,052.5 | 11,350.62 | 9,982.58 | 8,436.18 | 6,865.85 | 5,359.54 | 4,012.39 |
Secured Loans | 1,922.78 | 288.75 | 841.5 | 1,314.36 | 1,594.43 | 376.19 | 498.65 | 1,002.71 | 1,884.01 | 2,070.06 |
Unsecured Loans | 2,280.38 | 1,606.14 | 3,200.46 | 2,427.1 | 2,925.37 | 3,342.81 | 2,555.26 | 3,162.72 | 1,400.72 | 855.1 |
Total Debt | 4,203.16 | 1,894.89 | 4,041.96 | 3,741.46 | 4,519.8 | 3,719 | 3,053.91 | 4,165.43 | 3,284.73 | 2,925.16 |
Other Liabilities | 87.31 | 5.03 | 0 | 42.68 | 22.64 | 33.6 | 20.87 | 21.26 | 22.65 | 8.3 |
Total Liabilities | 22,204.64 | 19,017.26 | 19,966.57 | 16,836.64 | 15,893.06 | 13,735.18 | 11,510.96 | 11,052.54 | 8,666.92 | 6,945.85 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 6,214.72 | 5,724.9 | 6,688.9 | 6,180.91 | 5,446.15 | 4,292.18 | 3,758.18 | 2,830.78 | 3,507.54 | 3,008.82 |
Less : Accumulated Depreciation | 2,527.22 | 2,139.07 | 2,216.83 | 1,763.11 | 1,296.45 | 899.21 | 546.56 | 262.65 | 1,317.53 | 1,070.88 |
Net Block | 3,687.5 | 3,585.83 | 4,472.07 | 4,417.8 | 4,149.7 | 3,392.97 | 3,211.62 | 2,568.13 | 2,190.01 | 1,937.94 |
Capital Work in Progress | 239.09 | 225.15 | 734.89 | 814.85 | 789.01 | 1,143.98 | 906.98 | 742.14 | 227.19 | 203.89 |
Investments | 8,221.78 | 6,584.36 | 5,009.93 | 2,527.41 | 2,339.06 | 1,967.5 | 1,681.95 | 1,183.35 | 1,012.75 | 872.62 |
Inventories | 4,125.26 | 3,356.18 | 4,841.38 | 4,359.57 | 3,971.26 | 3,409.23 | 2,433.62 | 2,431.6 | 2,145.05 | 1,711.81 |
Sundry Debtors | 4,560.26 | 3,973.24 | 5,928.01 | 5,785 | 5,232.07 | 4,468.23 | 3,773.63 | 4,380.97 | 3,708.94 | 2,970.12 |
Cash and Bank Balance | 132.14 | 50.78 | 386.18 | 86.16 | 75.77 | 245.9 | 33.64 | 330.81 | 11.13 | 9.72 |
Loans and Advances | 905.97 | 2,454.9 | 1,051.4 | 1,057.55 | 1,129.22 | 857.82 | 662.44 | 631.1 | 483.32 | 389.5 |
Total Current Assets | 9,723.63 | 9,835.1 | 12,206.97 | 11,288.28 | 10,408.32 | 8,981.18 | 6,903.33 | 7,774.48 | 6,348.44 | 5,081.15 |
Current Liabilities | 2,391.01 | 2,243.3 | 2,539.03 | 2,526.66 | 2,120.15 | 1,960.64 | 1,450.46 | 1,456.07 | 1,262.6 | 1,318.25 |
Provisions | 122.09 | 103.36 | 250.01 | 115.27 | 96.51 | 74.54 | 61.5 | 56.95 | 86.02 | 106.18 |
Total Current Liabilities & Provisions | 2,513.1 | 2,346.66 | 2,789.04 | 2,641.93 | 2,216.66 | 2,035.18 | 1,511.96 | 1,513.02 | 1,348.62 | 1,424.43 |
Net Current Assets | 7,210.53 | 7,488.44 | 9,417.93 | 8,646.35 | 8,191.66 | 6,946 | 5,391.37 | 6,261.46 | 4,999.82 | 3,656.72 |
Deferred Tax Assets | 55.24 | 43.82 | 68.61 | 411.92 | 439.87 | 382.06 | 333.52 | 267.97 | 28.55 | 18.56 |
Deferred Tax Liability | 271.15 | 280.85 | 501.99 | 496.96 | 470.87 | 405.54 | 333.44 | 261.11 | 238.89 | 223.81 |
Net Deferred Tax | -215.91 | -237.03 | -433.38 | -85.04 | -31 | -23.48 | 0.08 | 6.86 | -210.34 | -205.25 |
Other Assets | 3,061.65 | 1,370.51 | 765.13 | 515.27 | 454.63 | 308.21 | 318.96 | 290.6 | 447.49 | 479.93 |
Total Assets | 22,204.64 | 19,017.26 | 19,966.57 | 16,836.64 | 15,893.06 | 13,735.18 | 11,510.96 | 11,052.54 | 8,666.92 | 6,945.85 |
Contingent Liabilities | 120.26 | 152.93 | 770.1 | 2,006.56 | 2,496.37 | 1,214.54 | 427.41 | 799.8 | 558.92 | 231.1 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 2,612.5 |
Depreciation | 1,244.58 |
Interest (Net) | -16.95 |
P/L on Sales of Assets | -13.23 |
Prov. and W/O (Net) | 69.08 |
P/L in Forex | 310.46 |
Total Adjustments (PBT and Ext... | 1,586.47 |
Operating Profit before Workin... | 4,198.97 |
Trade and 0ther Receivables | -432.11 |
Inventories | -926.7 |
Trade Payables | 707.65 |
Loans and Advances | 1.04 |
Total Adjustments (OP before W... | -1,094.98 |
Cash Generated from/(used in) ... | 3,103.99 |
Direct Taxes Paid | -717.24 |
Total Adjustments(Cash Generat... | -717.24 |
Cash Flow before Extraordinary... | 2,386.75 |
Net Cash from Operating Activi... | 2,386.75 |
Purchased of Fixed Assets | -2,720.4 |
Sale of Fixed Assets | 11.09 |
Purchase of Investments | -2,014.1 |
Sale of Investments | 2,456.85 |
Interest Received | 146.62 |
Acquisition of Companies | -28.05 |
Net Cash used in Investing Act... | -3,977.81 |
Proceed from 0ther Long Term B... | 393.58 |
Proceed from Short Tem Borrowi... | 2,069.68 |
Of the Long Tem Borrowings | -5.65 |
Of Financial Liabilities | -92.47 |
Dividend Paid | -439.53 |
Interest Paid | -111.2 |
Net Cash used in Financing Act... | 1,814.41 |
Net Profit before Tax and Extr... | 1,614.35 |
Depreciation | 435.35 |
Interest (Net) | -72.64 |
Dividend Received | 164.87 |
P/L on Sales of Assets | -13.35 |
Prov. and W/O (Net) | 13.47 |
P/L in Forex | -13.99 |
Total Adjustments (PBT and Ext... | 175.19 |
Operating Profit before Workin... | 1,789.54 |
Trade and 0ther Receivables | -536.6 |
Inventories | -739.9 |
Trade Payables | 78.89 |
Loans and Advances | 1.05 |
Total Adjustments (OP before W... | 332.21 |
Cash Generated from/(used in) ... | 2,121.75 |
Direct Taxes Paid | -300.59 |
Total Adjustments(Cash Generat... | -300.59 |
Cash Flow before Extraordinary... | 1,821.16 |
Net Cash from Operating Activi... | 1,821.16 |
Purchased of Fixed Assets | -358.29 |
Sale of Fixed Assets | 23.22 |
Purchase of Investments | -939.1 |
Interest Received | 79.71 |
Net Cash used in Investing Act... | -3,459.2 |
Proceed from Short Tem Borrowi... | 2,287.31 |
Of Financial Liabilities | -20.96 |
Dividend Paid | -439.53 |
Interest Paid | -107.34 |
Net Cash used in Financing Act... | 1,719.48 |
Company Details
Registered Office |
|
Address | Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet |
City | Hyderabad |
State | Telangana |
Pin Code | 500038 |
Tel. No. | 91-40-23736370 |
Fax. No. | 91-40-23747340 |
cs@aurobindo.com; investorgrievances@aurobindo.com | |
Internet | http://www.aurobindo.com |
Registrars |
|
Address | Plot No 2 Maitrivihar |
City | Hyderabad |
State | Telangana |
Pin Code | 500038 |
Tel. No. | 91-40-23736370 |
Fax. No. | 91-40-23747340 |
cs@aurobindo.com; investorgrievances@aurobindo.com | |
Internet | http://www.aurobindo.com |
Management |
|
Name | Designation |
K Ragunathan | Chairman & Independent Directo |
Kambam Nityananda Reddy | Executive Director |
M Sivakumaran | Executive Director |
M Madan Mohan Reddy | Executive Director |
P V Ramprasad Reddy | Non Executive Director |
Savita Mahajan | Independent Non Exe. Director |
Girish Paman Vanvari | Independent Non Exe. Director |
P Sarath Chandra Reddy | Independent Non Exe. Director |
Santanu Mukherjee | Independent Director |
Deepali Pant Joshi | Additional Director |